Current insights of applying MRI in Graves' ophthalmopathy

Front Endocrinol (Lausanne). 2022 Sep 29:13:991588. doi: 10.3389/fendo.2022.991588. eCollection 2022.

Abstract

Graves' ophthalmopathy (GO) is an autoimmune disease related to Grave's disease (GD). The therapeutic strategies for GO patients are based on precise assessment of the activity and severity of the disease. However, the current assessment systems require development to accommodate updates in treatment protocols. As an important adjunct examination, magnetic resonance imaging (MRI) can help physicians evaluate GO more accurately. With the continuous updating of MRI technology and the deepening understanding of GO, the assessment of this disease by MRI has gone through a stage from qualitative to precise quantification, making it possible for clinicians to monitor the microstructural changes behind the eyeball and better integrate clinical manifestations with pathology. In this review, we use orbital structures as a classification to combine pathological changes with MRI features. We also review some MRI techniques applied to GO clinical practice, such as disease classification and regions of interest selection.

Keywords: Graves ophthalmopathy; MRI; assessment; extraocular muscles; orbital fat.

Publication types

  • Systematic Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Graves Disease*
  • Graves Ophthalmopathy* / diagnosis
  • Humans
  • Magnetic Resonance Imaging / methods